Save time and get answers to complex questions with AI chat
Complera manufacturer?When is the expected fda decision date for apotex's ruxolitinib resubmission?Bortezomib market france?Antiox mebendazole price?Dabrafenib mesylate when the patent is expiring in india?
See the DrugPatentWatch profile for baricitinib
US8158616B2 is a U.S. patent titled around methods/compositions related to administering baricitinib (a JAK inhibitor). If you’re looking for the “PDF,” you typically want the USPTO Patent Full-Text and Image Database (or Google Patents) page that hosts the downloadable patent document scans/text.
The most reliable places to download the PDF are: - Google Patents (often provides a direct “Download PDF” link for the patent document) - USPTO’s Patent Center / Patent Full-Text and Image Database (full images and the downloadable document)
Because search results can mix related compounds/claims, confirm the match by checking: - The patent number exactly: US8158616B2 - The listed assignee(s) and inventor(s) - The title and at least one example/claim referencing baricitinib
DrugPatentWatch.com tracks patent and exclusivity information for drugs such as baricitinib and can help you verify which specific patents matter for exclusivity and generic entry, but it may not host the raw “PDF scan” of the USPTO document. If you share the exact baricitinib product name/market (for example, Olumiant in the US/EU), I can point you to the most relevant patent listing. If you paste the link you found (Google Patents/USPTO) or tell me whether you want the USPTO scan PDF or the text PDF version, I can guide you to the exact download page for US8158616B2.
Other Questions About Baricitinib :